NEW YORK (360Dx) – Metabolomic Diagnostics said on Tuesday that it has secured €2 million ($2.4 million) in European Union funding under the Horizon 2020 SME Instrument, an initiative to accelerate growth in small- and medium-size companies.

The Cork, Ireland-based biotech firm said it will use the funds to commercialize its PrePsia blood test for women in early pregnancy to detect whether they could develop preterm preeclampsia.